Purine de novo synthesis as the basis of synergism of methotrexate and 6-mercaptopurine in human malignant lymphoblasts of different lineages
- 1 June 1988
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 37 (12) , 2321-2327
- https://doi.org/10.1016/0006-2952(88)90358-9
Abstract
No abstract availableThis publication has 58 references indexed in Scilit:
- Alterations of the hprt gene in human in vivo-derived 6-thioguanine-resistant T lymphocytesNature, 1985
- Hypoxanthine-guanine phosphoribosyltransferase-independent toxicity of azathioprine in human lymphoblastsBiochemical Pharmacology, 1984
- Purine metabolism in relation to leukemia and lymphoid cell differentiationLeukemia Research, 1983
- Purine metabolism in childhood acute lymphoblastic leukemia: Biochemical markers for diagnosis and chemotherapyLeukemia Research, 1983
- The correlation of adenosine deaminase and purine nucleoside phosphorylase activities in human lymphocytes subpopulations and in various lymphoid malignanciesLeukemia Research, 1982
- Studies on the Biochemical Sequelae of Therapy in Thy-Acute Lymphoblastic Leukaemia with the Adenosine Deaminase Inhibitor 2’DeoxycoformycinBritish Journal of Haematology, 1981
- Biochemical Markers in Lymphoid MalignancyNew England Journal of Medicine, 1980
- REMISSION INDUCTION WITH ADENOSINE-DEAMINASE INHIBITOR 2'-DEOXYCOFORMYCIN IN THY-LYMPHOBLASTIC LEUKÆMIAThe Lancet, 1980
- Nucleotide-metabolizing enzymes and lymphocyte differentiationMolecular and Cellular Biochemistry, 1979
- Studies of Sequential and Combination Antimetabolite Therapy in Acute Leukemia: 6-Mercaptopurine and MethotrexateBlood, 1961